To Treat or Not to Treat: Low-Dose Alteplase for Patients With Acute Ischemic Stroke Taking Direct Oral Anticoagulants Within 24 Hours.
Publication
, Journal Article
Kam, W; Xian, Y
Published in: J Am Heart Assoc
October 4, 2022
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Am Heart Assoc
DOI
EISSN
2047-9980
Publication Date
October 4, 2022
Volume
11
Issue
19
Start / End Page
e027238
Location
England
Related Subject Headings
- Treatment Outcome
- Tissue Plasminogen Activator
- Thrombolytic Therapy
- Stroke
- Ischemic Stroke
- Humans
- Fibrinolytic Agents
- Brain Ischemia
- Anticoagulants
- 3201 Cardiovascular medicine and haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Kam, W., & Xian, Y. (2022). To Treat or Not to Treat: Low-Dose Alteplase for Patients With Acute Ischemic Stroke Taking Direct Oral Anticoagulants Within 24 Hours. J Am Heart Assoc, 11(19), e027238. https://doi.org/10.1161/JAHA.122.027238
Kam, Wayneho, and Ying Xian. “To Treat or Not to Treat: Low-Dose Alteplase for Patients With Acute Ischemic Stroke Taking Direct Oral Anticoagulants Within 24 Hours.” J Am Heart Assoc 11, no. 19 (October 4, 2022): e027238. https://doi.org/10.1161/JAHA.122.027238.
Kam W, Xian Y. To Treat or Not to Treat: Low-Dose Alteplase for Patients With Acute Ischemic Stroke Taking Direct Oral Anticoagulants Within 24 Hours. J Am Heart Assoc. 2022 Oct 4;11(19):e027238.
Kam, Wayneho, and Ying Xian. “To Treat or Not to Treat: Low-Dose Alteplase for Patients With Acute Ischemic Stroke Taking Direct Oral Anticoagulants Within 24 Hours.” J Am Heart Assoc, vol. 11, no. 19, Oct. 2022, p. e027238. Pubmed, doi:10.1161/JAHA.122.027238.
Kam W, Xian Y. To Treat or Not to Treat: Low-Dose Alteplase for Patients With Acute Ischemic Stroke Taking Direct Oral Anticoagulants Within 24 Hours. J Am Heart Assoc. 2022 Oct 4;11(19):e027238.
Published In
J Am Heart Assoc
DOI
EISSN
2047-9980
Publication Date
October 4, 2022
Volume
11
Issue
19
Start / End Page
e027238
Location
England
Related Subject Headings
- Treatment Outcome
- Tissue Plasminogen Activator
- Thrombolytic Therapy
- Stroke
- Ischemic Stroke
- Humans
- Fibrinolytic Agents
- Brain Ischemia
- Anticoagulants
- 3201 Cardiovascular medicine and haematology